• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53和C-myc基因在肝癌及癌旁组织中的表达及其临床意义

Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues.

作者信息

Niu Zhao-Shan, Li Bo-Kian, Wang Mei

机构信息

Department of Pathology, Medical College of Qingdao University, Qingdao 266021, Shandong Province, China.

出版信息

World J Gastroenterol. 2002 Oct;8(5):822-6. doi: 10.3748/wjg.v8.i5.822.

DOI:10.3748/wjg.v8.i5.822
PMID:12378623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4656568/
Abstract

AIM

To investigate the possible roles of p53 and C-myc genes in the primary hepatocellular carcinogenesis and the relationship between the liver hyperplastic nodule (LHN) and hepatocellular carcinoma(HCC).

METHODS

The expression of p53 and C-myc genes was detected immunohistochemically in 73 and 60 cases of HCC and pericarcinomatous tissues, respectively.

RESULTS

The positive expression of p53 in HCC was significantly higher than that in pericarcinomatous tissues (P<0.05). In pericarcinomatous tissues, the p53 expression was observed only in LHN, but not in liver cirrhosis (LC) and normal liver tissues. The positive expression rate of C-myc in HCC or LHN was significantly higher than that in LC or normal liver tissues (P<0.05 and P<0.01), however, no significant difference was found between HCC and LHN (P>0.05). The positive expression rate of p53 and C-myc in HCC was correlated with the histological differentiation, that in the poorly differentiated was significantly higher than that in well differentiated samples (P<0.05).

CONCLUSION

The overexpression of p53 and C-myc genes might play a role in the carcinogenesis of HCC; And LHN seems a preneoplastic lesion related to hepatocarcinogenesis; No evidence supports that LC contribute directly to the hepatocarcinogenesis.

摘要

目的

探讨p53和C-myc基因在原发性肝细胞癌发生中的可能作用以及肝增生结节(LHN)与肝细胞癌(HCC)之间的关系。

方法

分别采用免疫组织化学方法检测73例HCC及癌旁组织和60例HCC及癌旁组织中p53和C-myc基因的表达。

结果

HCC中p53的阳性表达显著高于癌旁组织(P<0.05)。在癌旁组织中,仅在LHN中观察到p53表达,而在肝硬化(LC)和正常肝组织中未观察到。HCC或LHN中C-myc的阳性表达率显著高于LC或正常肝组织(P<0.05和P<0.01),然而,HCC与LHN之间未发现显著差异(P>0.05)。HCC中p53和C-myc的阳性表达率与组织学分化相关,低分化样本中的阳性表达率显著高于高分化样本(P<0.05)。

结论

p53和C-myc基因的过表达可能在HCC的发生中起作用;并且LHN似乎是与肝癌发生相关的癌前病变;没有证据支持LC直接促成肝癌发生。

相似文献

1
Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues.p53和C-myc基因在肝癌及癌旁组织中的表达及其临床意义
World J Gastroenterol. 2002 Oct;8(5):822-6. doi: 10.3748/wjg.v8.i5.822.
2
The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.伴有和不伴有肝硬化的丙型肝炎病毒相关肝细胞癌中p53、c-Jun、c-Myc和p21的差异免疫组化表达
Appl Immunohistochem Mol Morphol. 2016 Feb;24(2):75-87. doi: 10.1097/PAI.0000000000000155.
3
Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.c-erbB-2和谷胱甘肽S-转移酶-π在肝细胞癌及其癌旁组织中的表达
World J Gastroenterol. 2005 Jul 28;11(28):4404-8. doi: 10.3748/wjg.v11.i28.4404.
4
Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.人肝细胞癌中p53和c-myc表达及细胞增殖的比较分析——一种增强免疫组织化学方法
J Cancer Res Clin Oncol. 1993;119(12):737-44. doi: 10.1007/BF01195346.
5
Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.p53 基因敲除小鼠中转分化和去分化产生的肝细胞胆管细胞癌。
Cancer Sci. 2021 Aug;112(8):3111-3124. doi: 10.1111/cas.14996. Epub 2021 Jun 27.
6
Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis.小鼠肝癌发生过程中卵圆细胞的分布及c-myc mRNA表达
Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):433-9.
7
[The effect of HCV NS3 protein on expression of p53 gene protein in hepatocarcinogenesis].[丙型肝炎病毒NS3蛋白在肝癌发生过程中对p53基因蛋白表达的影响]
Zhonghua Yi Xue Za Zhi. 1998 Apr;78(4):278-80.
8
Two-stage model of chemically induced hepatocellular carcinoma in mouse.小鼠化学诱导肝细胞癌的两阶段模型。
Oncol Res. 2013;20(11):517-28. doi: 10.3727/096504013X13747716581336.
9
[Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].[人肝细胞癌中c-myc和p53基因的过表达——免疫组织化学和原位杂交研究]
Zhonghua Zhong Liu Za Zhi. 1995 Nov;17(6):415-7.
10
[Immunohistochemical detection of p21ras, c-myc and p53 oncoproteins in hepatocellular carcinoma and in non-neoplastic liver tissue].[肝细胞癌及非肿瘤性肝组织中p21ras、c-myc和p53癌蛋白的免疫组织化学检测]
Arq Gastroenterol. 2004 Oct-Dec;41(4):225-8. doi: 10.1590/s0004-28032004000400005. Epub 2005 Mar 29.

引用本文的文献

1
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.去分化过程驱动的表观遗传改变中肺癌干细胞的分子特征。
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
2
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.长链非编码 RNA CSMD1-1 通过激活 MYC 信号促进肝癌的进展。
Theranostics. 2020 Jun 12;10(17):7527-7544. doi: 10.7150/thno.45989. eCollection 2020.
3
Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948.磷酸肌醇 3-激酶,催化,α多肽 RNA 干扰抑制结肠癌细胞 SW948 的生长。
World J Gastroenterol. 2012 Jul 14;18(26):3458-64. doi: 10.3748/wjg.v18.i26.3458.
4
The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.土耳其肝细胞癌(HCC)患者中P53基因第249位密码子突变的发生率。
J Gastrointest Cancer. 2010 Sep;41(3):185-9. doi: 10.1007/s12029-010-9140-5.
5
ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.短发夹RNA介导的β-连环蛋白基因沉默抑制人结肠癌细胞生长。
World J Gastroenterol. 2007 Dec 28;13(48):6581-7. doi: 10.3748/wjg.v13.i48.6581.
6
Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection.c-myc、Ki-67、MMP-2和VEGF表达对接受肿瘤切除的肝细胞癌患者预后的影响。
World J Gastroenterol. 2004 May 15;10(10):1533-6. doi: 10.3748/wjg.v10.i10.1533.
7
Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.靶向端粒酶逆转录酶(hTERT)启动子的反义寡核苷酸可抑制肝癌细胞生长。
World J Gastroenterol. 2004 Feb 1;10(3):366-70. doi: 10.3748/wjg.v10.i3.366.
8
Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.过氧化物酶体增殖物激活受体γ配体抑制人肝癌BEL - 7402细胞的生长并诱导其凋亡。
World J Gastroenterol. 2003 Aug;9(8):1683-8. doi: 10.3748/wjg.v9.i8.1683.
9
Maxizyme-mediated specific inhibition on mutant-type p53 in vitro.Maxizyme在体外对突变型p53的特异性抑制作用。
World J Gastroenterol. 2003 Jul;9(7):1571-5. doi: 10.3748/wjg.v9.i7.1571.
10
PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells.过氧化物酶体增殖物激活受体γ(PPARγ)信号通路激活导致肝癌细胞系(HepG2)凋亡及环氧化酶-2(COX-2)受抑制。
World J Gastroenterol. 2003 Jun;9(6):1220-6. doi: 10.3748/wjg.v9.i6.1220.

本文引用的文献

1
Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats.内毒素对硫代乙酰胺诱导的大鼠肝癌发生过程中ras、p53和bcl-2癌蛋白表达的影响。
World J Gastroenterol. 1997 Dec 15;3(4):213-7. doi: 10.3748/wjg.v3.i4.213.
2
[Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].[肝硬化和肝细胞癌中p53和bcl-2蛋白对细胞凋亡和细胞增殖的调控]
Hunan Yi Ke Da Xue Xue Bao. 1999;24(4):325-8.
3
Gene expression patterns in human liver cancers.人类肝癌中的基因表达模式。
Mol Biol Cell. 2002 Jun;13(6):1929-39. doi: 10.1091/mbc.02-02-0023.
4
P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.P53免疫组化评分:肝细胞癌切除术后患者的独立预后标志物
World J Gastroenterol. 2002 Jun;8(3):459-63. doi: 10.3748/wjg.v8.i3.459.
5
The prognostic molecular markers in hepatocellular carcinoma.肝细胞癌的预后分子标志物
World J Gastroenterol. 2002 Jun;8(3):385-92. doi: 10.3748/wjg.v8.i3.385.
6
[Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization].[应用间期荧光原位杂交技术检测原发性肝癌中c-myc癌基因扩增的临床意义]
Zhonghua Bing Li Xue Za Zhi. 2001 Jun;30(3):180-2.
7
[p53 gene mutation in hepatocellular carcinoma].[肝细胞癌中的p53基因突变]
Zhonghua Wai Ke Za Zhi. 1998 Sep;36(9):531-2.
8
Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice.土拨鼠乙型肝炎病毒诱导的小鼠肝细胞癌中的差异表达基因
World J Gastroenterol. 2001 Aug;7(4):575-8. doi: 10.3748/wjg.v7.i4.575.
9
Hepatocellular carcinoma--cause, treatment and metastasis.肝细胞癌——病因、治疗与转移
World J Gastroenterol. 2001 Aug;7(4):445-54. doi: 10.3748/wjg.v7.i4.445.
10
Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer.细胞凋亡功能及Bcl-2、p53和C-myc蛋白在胃癌发生发展中的表达
World J Gastroenterol. 2001 Jun;7(3):403-6. doi: 10.3748/wjg.v7.i3.403.